Cargando…
The International Prospective Glanzmann Thrombasthenia Registry: Pediatric Treatment and Outcomes
Background Standard treatment for Glanzmann thrombasthenia (GT), a severe inherited bleeding disorder, is platelet transfusion. Recombinant activated factor VII (rFVIIa) is reported to be effective in GT with platelet antibodies and/or refractoriness to platelet transfusions. Methods We evaluated...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Georg Thieme Verlag KG
2019
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6742499/ https://www.ncbi.nlm.nih.gov/pubmed/31523745 http://dx.doi.org/10.1055/s-0039-1696657 |